Originally Posted by
pierre
I received the following reply from PEB to my request for clarification of the term "500 monthly users" in their recent communication to shareholders following the AUA meeting:
"The “users” we refer to is the ordering clinician, of which most are US based. Our Account Executive team in the US are focused on increasing test adoption by urologists, who are the users of the test to assist in the assessment of their patients."
That's positive though, of course, the next question is: What is the average number of tests per month ordered by each clinician? Hopefully that information might be revealed in the FY report at month-end.
I did a Google search and found that in 2019 the US urologist population totaled around 13,000. That means only ~4% of them are using Cxbladder so there's plenty of room for growth. :)